查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1865416

全球無激素助眠產品市場：預測至2032年－按成分類型、產品形式、通路、最終用戶和地區分類的分析

Hormone Free Sleep Aids Market Forecasts to 2032 - Global Analysis By Ingredient Type, Product Form, Distribution Channel, End User, and By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的一項研究，預計到 2025 年，全球無激素助眠劑市場價值將達到 100 億美元，到 2032 年將達到 167 億美元。

預計在預測期內，該市場將以7.6%的複合年成長率成長。無激素助眠產品是指不含荷爾蒙的補充品或配方，旨在促進安穩睡眠，同時不擾亂人體荷爾蒙平衡。與褪黑素類產品不同，這些補充劑通常依靠草藥萃取物、胺基酸或礦物質，例如纈草根、鎂和L-茶胺酸，來幫助放鬆身心，改善睡眠品質。這些產品旨在幫助您入睡並延長睡眠時間，而不會擾亂您的晝夜節律或導致荷爾蒙依賴。

根據美國疾病管制與預防中心 (CDC) 的數據，到 2022 年，美國各州將有 30% 至 46% 的美國睡眠不足，這項持續存在的公共衛生挑戰正在推動非荷爾蒙助眠劑的使用。

睡眠障礙呈上升趨勢

失眠、不寧腿症候群和睡眠呼吸中止症等睡眠障礙的日益增多，是推動無激素助眠產品市場發展的主要動力。隨著人們對睡眠健康的日益關注，消費者正積極尋求非荷爾蒙類的睡眠障礙解決方案，以避免對內分泌系統造成不利影響。此外，壓力水平上升、生活方式改變和螢幕使用等不利於睡眠衛生的因素也進一步加劇了這一趨勢。因此，對天然無激素解決方案的需求持續成長，推動了已開發地區和新興市場市場的蓬勃發展。

缺乏標準化劑量和法律規範不力

許多產品依賴缺乏統一臨床檢驗的草藥或營養成分，導致其療效和安全性參差不齊。缺乏標準化通訊協定會削弱消費者信任，阻礙產品更廣泛應用，尤其是在醫療保健和機構領域。此外，各地監管法規的碎片化也使產品核可和標籤標註變得複雜，為希望拓展業務或進入新市場的製造商設置了障礙。

開發經臨床驗證的複方製劑

透過整合鎂、L-茶胺酸和纈草根等協同成分，製造商可以在維持產品不含荷爾蒙特性的同時，提升治療效果。此類創新吸引了注重健康、尋求針對性、多功能睡眠支援的消費者。此外，臨床檢驗和透明的標籤資訊增強了產品的可信度，並有助於其進入受監管的零售和藥房管道。隨著研究的不斷深入，此類配方有望在競爭激烈的市場環境中推動產品差異化和優質化。

來自處方藥和非處方助眠藥物的競爭

處方藥和非處方安眠藥是治療嚴重睡眠障礙的首選，因為它們通常能快速緩解症狀，並有大量的臨床數據支持。此外，處方藥的積極行銷和保險覆蓋範圍可能會限制消費者獲得天然產品。這種競爭環境可能會阻礙市場滲透，尤其是在那些不熟悉無激素產品或對缺乏醫學證據的益處持懷疑態度的使用者群體中。

新冠疫情的影響：

新冠疫情對睡眠模式產生了顯著影響，導致包括無激素產品在內的助眠產品需求激增。封鎖、遠距辦公和焦慮情緒的加劇擾亂了晝夜節律，促使消費者尋求非成癮性治療方法。儘管供應鏈中斷最初影響了產品供應，但電子商務管道促進了市場的復甦和擴張。此外，疫情加速了人們對健康和預防保健的關注，使無激素助眠產品成為長期解決方案。這種消費行為的轉變將持續支撐疫情後市場的持續成長。

預計在預測期內，草藥/植物萃取物細分市場將佔據最大的市場佔有率。

由於草本/植物萃取物產品廣受消費者認可且​​天然，預計在預測期內將佔據最大的市場佔有率。洋甘菊、纈草根和西番蓮等成分傳統上用於助眠，且被認為安全無成癮性。膠囊、茶劑和酊劑等多種劑型進一步提高了其可及性。此外，消費者對潔淨標示植物來源保健產品的興趣日益濃厚，也推動了市場需求。該細分市場與整體健康趨勢的契合度有望使其在整個預測期內保持主導地位。

預計在預測期內，軟糖和咀嚼片細分市場將實現最高的複合年成長率。

由於其便利性、偏好和對年輕消費者的吸引力，預計在預測期內，軟糖和咀嚼片細分市場將實現最高成長率。這些劑型簡化了服用方式，無需吞服水或藥片，使其成為外出攜帶的理想選擇。此外，製造商正透過提供無糖、純素和多種口味選擇來不斷創新，以擴大其消費群體。隨著功能性糖果甜點在膳食補充劑領域日益普及，軟糖和咀嚼片產品有望超越傳統產品，推動零售和線上通路的強勁成長。

佔比最大的地區：

預計在預測期內，北美將佔據最大的市場佔有率，這主要得益於該地區對睡眠健康的高度重視、完善的健康基礎設施以及良好的消費支出。該地區對預防性醫療保健的積極態度以及對自然療法的偏好，推動了相關產品的強勁成長。此外，主要市場參與者的存在以及零售通路的廣泛覆蓋範圍也鞏固了其市場主導地位。監管部門對膳食補充劑的支持以及針對非荷爾蒙睡眠解決方案的臨床研究不斷增加，進一步強化了北美作為最大區域貢獻者的地位。

複合年成長率最高的地區：

預計亞太地區在預測期內將實現最高的複合年成長率，這主要得益於都市化加快、生活方式相關的睡眠問題日益嚴重以及中產階級在醫療保健方面支出不斷成長。中國、印度和日本等國家對天然保健產品（包括助眠產品）的需求正在增加。此外，消費者對傳統醫學體系和草藥的親和性也推動了其接受度。隨著電子商務滲透率的提高和法規結構的不斷完善，該地區展現出巨大的成長潛力，使其成為成長最快的市場區隔。

免費客製化服務

訂閱本報告的用戶可從以下免費自訂選項中選擇一項：

  • 公司簡介
    • 對最多三家其他公司進行全面分析
    • 對主要企業進行SWOT分析（最多3家公司）
  • 區域分類
    • 根據客戶興趣對主要國家進行市場估算、預測和複合年成長率分析（註：基於可行性檢查）
  • 競爭基準化分析
    • 基於產品系列、地域覆蓋和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 引言

  • 概述
  • 相關利益者
  • 分析範圍
  • 分析方法
    • 資料探勘
    • 數據分析
    • 數據檢驗
    • 分析方法
  • 分析材料
    • 原始研究資料
    • 二手研究資訊來源
    • 先決條件

第3章 市場趨勢分析

  • 介紹
  • 促進要素
  • 抑制因素
  • 市場機遇
  • 威脅
  • 終端用戶分析
  • 新興市場
  • 新冠疫情的感染疾病

第4章 波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代產品的威脅
  • 新參與企業的威脅
  • 公司間的競爭

5. 全球無激素助眠產品市場（依成分類型分類）

  • 介紹
  • 草本/植物萃取物
    • 纈草根
    • 洋甘菊
    • 西番蓮
    • 薰衣草
    • 睡茄
    • 其他植物
  • 胺基酸及其衍生物
    • L-茶氨酸
    • 色氨酸/5-羥色氨酸
    • GABA（γ-氨基丁酸）
    • 甘胺酸
  • 礦物質和維生素
    • 鎂
    • 維生素D、B群維生素
  • 其他成分

6. 全球無激素助眠產品市場（依產品形式分類）

  • 介紹
  • 膠囊和片劑
  • 軟糖/咀嚼片
  • 液體和噴霧劑
  • 粉末/條狀包裝
  • 茶和機能飲料

7. 全球無激素助眠產品市場（依通路分類）

  • 介紹
  • 線下分發
    • 零售藥局和藥局
    • 超級市場，大賣場
    • 健康保健商店
  • 線上發行
    • 電子商務平台
    • 企業自有網站（DTC）

8. 全球無激素助眠產品市場（依最終用戶分類）

  • 介紹
  • 成年人（18-60歲）
  • 老年人（60歲以上）
  • 兒童（青少年）

9. 全球無激素助眠產品市場（依地區分類）

  • 介紹
  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 亞太其他地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 其他南美洲國家
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲地區

第10章：主要趨勢

  • 合約、商業夥伴關係和合資企業
  • 企業合併（M&A）
  • 新產品發布
  • 業務拓展
  • 其他關鍵策略

第11章 企業概況

  • Natrol LLC
  • OLLY Public Benefit Corporation
  • NOW Foods（NOW Health Group, Inc.）
  • Herbalife Nutrition Ltd.
  • Church & Dwight Co., Inc.
  • The Nature's Bounty Co.
  • GNC Holdings LLC
  • Swanson Health Products, Inc.
  • Thorne HealthTech Inc.
  • Pharmavite LLC
  • Life Extension（Life Extension Foundation）
  • Solgar, Inc.
  • Pure Encapsulations LLC
  • Jarrow Formulas, Inc.
  • Amway Corporation
  • Nestle SA
  • Blackmores Limited
  • By-Health Co., Ltd.
Product Code: SMRC32195

According to Stratistics MRC, the Global Hormone Free Sleep Aids Market is accounted for $10.0 billion in 2025 and is expected to reach $16.7 billion by 2032, growing at a CAGR of 7.6% during the forecast period. Hormone-free sleep aids are non-hormonal supplements or formulations designed to promote restful sleep without altering the body's endocrine balance. Unlike melatonin-based products, these aids typically rely on herbal extracts, amino acids, or minerals such as valerian root, magnesium, or L-theanine to support relaxation and improve sleep quality. These products aim to enhance sleep onset and duration without disrupting circadian rhythms or causing hormonal dependency.

According to the CDC, in 2022 between 30% and 46% of U.S. adults (by state) did not get sufficient sleep, a persistent public-health gap driving non-hormonal sleep aid use.

Market Dynamics:

Driver:

Rising prevalence of sleep disorders

The increasing incidence of sleep disorders such as insomnia, restless leg syndrome, and sleep apnea is a primary driver for the hormone-free sleep aids market. As awareness of sleep health grows, consumers are actively seeking non-hormonal alternatives to manage sleep disturbances without endocrine disruption. This trend is further supported by rising stress levels, lifestyle changes, and screen exposure, which contribute to poor sleep hygiene. Consequently, demand for natural, hormone-free solutions continues to expand, reinforcing market growth across both developed and emerging regions.

Restraint:

Lack of standardized dosing and regulatory oversight

Many products rely on herbal or nutritional ingredients that lack uniform clinical validation, leading to variability in efficacy and safety. This absence of standardized protocols can undermine consumer trust and restrict broader adoption, particularly in medical or institutional settings. Moreover, regulatory fragmentation across regions complicates product approvals and labeling, posing hurdles for manufacturers aiming to scale operations or enter new markets.

Opportunity:

Development of clinically-backed combination formulas

By integrating synergistic ingredients such as magnesium, L-theanine, and valerian root manufacturers can enhance therapeutic outcomes while maintaining hormone-free profiles. These innovations appeal to health-conscious consumers seeking targeted, multi-functional sleep support. Furthermore, clinical validation and transparent labeling can improve credibility and facilitate entry into regulated retail and pharmacy channels. As research advances, such formulations are expected to drive differentiation and premiumization within the competitive landscape.

Threat:

Competitions from prescription sleep medications and OTC drugs

Prescription sleep medications and OTC drugs often offer faster symptom relief and are backed by extensive clinical data, making them preferred choices for severe sleep disorders. Additionally, aggressive marketing and insurance coverage for prescription drugs can limit consumer exposure to natural options. This competitive dynamic may hinder market penetration, especially among users unfamiliar with hormone-free solutions or skeptical of their efficacy without medical endorsement.

Covid-19 Impact:

The COVID-19 pandemic significantly influenced sleep patterns, leading to heightened demand for sleep aids, including hormone-free options. Lockdowns, remote work, and increased anxiety disrupted circadian rhythms, prompting consumers to seek non-habit-forming remedies. While supply chain disruptions initially affected product availability, e-commerce channels facilitated market recovery and expansion. Moreover, the pandemic accelerated interest in wellness and preventive health, positioning hormone-free sleep aids as viable long-term solutions. This shift in consumer behavior continues to support sustained market momentum post-pandemic.

The herbal/botanical extracts segment is expected to be the largest during the forecast period

The herbal/botanical extracts segment is expected to account for the largest market share during the forecast period due to their widespread consumer acceptance and natural origin. Ingredients like chamomile, valerian root, and passionflower are traditionally used for sleep support and are perceived as safe and non-addictive. Their integration into various delivery formats capsules, teas, and tinctures further enhances accessibility. Additionally, growing interest in clean-label and plant-based wellness products reinforces demand. This segment's alignment with holistic health trends ensures its continued leadership throughout the forecast period.

The gummies and chewables segment is expected to have the highest CAGR during the forecast period

Over the forecast period, the gummies and chewables segment is predicted to witness the highest growth rate due to their convenience, palatability, and appeal among younger demographics. These formats simplify dosing and eliminate the need for water or swallowing pills, making them ideal for on-the-go use. Moreover, manufacturers are innovating with sugar-free, vegan, and flavored variants to broaden consumer reach. As functional confectionery gains traction in the nutraceutical space, gummies and chewables are expected to outperform traditional formats, driving robust growth across retail and online channels.

Region with largest share:

During the forecast period, the North America region is expected to hold the largest market share driven by high awareness of sleep health, established wellness infrastructure, and favorable consumer spending. The region's proactive approach to preventive care and preference for natural remedies supports strong adoption. Additionally, the presence of key market players and widespread retail availability contribute to its dominance. Regulatory support for dietary supplements and increasing clinical research on non-hormonal sleep solutions further reinforce North America's position as the largest regional contributor.

Region with highest CAGR:

Over the forecast period, the Asia Pacific region is anticipated to exhibit the highest CAGR fueled by rising urbanization, lifestyle-induced sleep issues, and expanding middle-class health expenditure. Countries like China, India, and Japan are experiencing increased demand for natural wellness products, including sleep aids. Moreover, traditional medicine systems and herbal familiarity enhance consumer receptivity. As e-commerce penetration deepens and regulatory frameworks evolve, the region offers substantial growth potential, positioning Asia Pacific as the fastest-growing market segment.

Key players in the market

Some of the key players in Hormone Free Sleep Aids Market include Natrol LLC, OLLY Public Benefit Corporation, NOW Foods (NOW Health Group, Inc.), Herbalife Nutrition Ltd., Church & Dwight Co., Inc., The Nature's Bounty Co., GNC Holdings LLC, Swanson Health Products, Inc., Thorne HealthTech Inc., Pharmavite LLC, Life Extension (Life Extension Foundation), Solgar, Inc., Pure Encapsulations LLC, Jarrow Formulas, Inc., Amway Corporation, Nestle S.A., Blackmores Limited, and By-Health Co., Ltd.

Key Developments:

In September 2024, OLLY, the leading wellness brand known for innovative benefit-forward supplements, has expanded its women's line with the launch of clinically studied Mellow Menopause, designed to support menopause and provide multi-symptom management for hot flashes, night sweats, mood, fatigue and sleep*. The product recently completed its clinical trial, with very promising results that show the efficacy and innovation behind the ingredients.

In September 2023, Natrol(R), a leading sleep, mood and stress supplement brand and #1 brand of melatonin^, is launching its first-ever sleep aid supplement without melatonin, Soothing Night(R), made with effective, clinically-tested ingredients designed to reduce occasional stress and promote longer, better sleep.

Ingredients Types Covered:

  • Herbal/Botanical Extracts
  • Amino Acids and Derivatives
  • Minerals and Vitamins
  • Other Ingredients

Product Forms Covered:

  • Capsules and Tablets
  • Gummies and Chewables
  • Liquids and Sprays
  • Powders and Stick Packs
  • Teas and Functional Beverages

Distribution Channels Covered:

  • Offline Distribution
  • Online Distribution

End Users Covered:

  • Adults (18-60 Years)
  • Geriatric Population (60+ Years)
  • Pediatric (Children/Adolescents)

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2024, 2025, 2026, 2028, and 2032
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Emerging Markets
  • 3.8 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Hormone Free Sleep Aids Market, By Ingredient Type

  • 5.1 Introduction
  • 5.2 Herbal/Botanical Extracts
    • 5.2.1 Valerian Root
    • 5.2.2 Chamomile
    • 5.2.3 Passionflower
    • 5.2.4 Lavender
    • 5.2.5 Ashwagandha
    • 5.2.6 Other Botanicals
  • 5.3 Amino Acids and Derivatives
    • 5.3.1 L-Theanine
    • 5.3.2 Tryptophan/5-HTP
    • 5.3.3 GABA (Gamma-Aminobutyric Acid)
    • 5.3.4 Glycine
  • 5.4 Minerals and Vitamins
    • 5.4.1 Magnesium
    • 5.4.2 Vitamin D, B-Complex
  • 5.5 Other Ingredients

6 Global Hormone Free Sleep Aids Market, By Product Form

  • 6.1 Introduction
  • 6.2 Capsules and Tablets
  • 6.3 Gummies and Chewables
  • 6.4 Liquids and Sprays
  • 6.5 Powders and Stick Packs
  • 6.6 Teas and Functional Beverages

7 Global Hormone Free Sleep Aids Market, By Distribution Channel

  • 7.1 Introduction
  • 7.2 Offline Distribution
    • 7.2.1 Retail Pharmacies and Drug Stores
    • 7.2.2 Supermarkets and Hypermarkets
    • 7.2.3 Health & Wellness Stores
  • 7.3 Online Distribution
    • 7.3.1 E-commerce Platforms
    • 7.3.2 Company-Owned Websites (DTC)

8 Global Hormone Free Sleep Aids Market, By End User

  • 8.1 Introduction
  • 8.2 Adults (18-60 Years)
  • 8.3 Geriatric Population (60+ Years)
  • 8.4 Pediatric (Children/Adolescents)

9 Global Hormone Free Sleep Aids Market, By Geography

  • 9.1 Introduction
  • 9.2 North America
    • 9.2.1 US
    • 9.2.2 Canada
    • 9.2.3 Mexico
  • 9.3 Europe
    • 9.3.1 Germany
    • 9.3.2 UK
    • 9.3.3 Italy
    • 9.3.4 France
    • 9.3.5 Spain
    • 9.3.6 Rest of Europe
  • 9.4 Asia Pacific
    • 9.4.1 Japan
    • 9.4.2 China
    • 9.4.3 India
    • 9.4.4 Australia
    • 9.4.5 New Zealand
    • 9.4.6 South Korea
    • 9.4.7 Rest of Asia Pacific
  • 9.5 South America
    • 9.5.1 Argentina
    • 9.5.2 Brazil
    • 9.5.3 Chile
    • 9.5.4 Rest of South America
  • 9.6 Middle East & Africa
    • 9.6.1 Saudi Arabia
    • 9.6.2 UAE
    • 9.6.3 Qatar
    • 9.6.4 South Africa
    • 9.6.5 Rest of Middle East & Africa

10 Key Developments

  • 10.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 10.2 Acquisitions & Mergers
  • 10.3 New Product Launch
  • 10.4 Expansions
  • 10.5 Other Key Strategies

11 Company Profiling

  • 11.1 Natrol LLC
  • 11.2 OLLY Public Benefit Corporation
  • 11.3 NOW Foods (NOW Health Group, Inc.)
  • 11.4 Herbalife Nutrition Ltd.
  • 11.5 Church & Dwight Co., Inc.
  • 11.6 The Nature's Bounty Co.
  • 11.7 GNC Holdings LLC
  • 11.8 Swanson Health Products, Inc.
  • 11.9 Thorne HealthTech Inc.
  • 11.10 Pharmavite LLC
  • 11.11 Life Extension (Life Extension Foundation)
  • 11.12 Solgar, Inc.
  • 11.13 Pure Encapsulations LLC
  • 11.14 Jarrow Formulas, Inc.
  • 11.15 Amway Corporation
  • 11.16 Nestle S.A.
  • 11.17 Blackmores Limited
  • 11.18 By-Health Co., Ltd.

List of Tables

  • Table 1 Global Hormone Free Sleep Aids Market Outlook, By Region (2024-2032) ($MN)
  • Table 2 Global Hormone Free Sleep Aids Market Outlook, By Ingredient Type (2024-2032) ($MN)
  • Table 3 Global Hormone Free Sleep Aids Market Outlook, By Herbal/Botanical Extracts (2024-2032) ($MN)
  • Table 4 Global Hormone Free Sleep Aids Market Outlook, By Valerian Root (2024-2032) ($MN)
  • Table 5 Global Hormone Free Sleep Aids Market Outlook, By Chamomile (2024-2032) ($MN)
  • Table 6 Global Hormone Free Sleep Aids Market Outlook, By Passionflower (2024-2032) ($MN)
  • Table 7 Global Hormone Free Sleep Aids Market Outlook, By Lavender (2024-2032) ($MN)
  • Table 8 Global Hormone Free Sleep Aids Market Outlook, By Ashwagandha (2024-2032) ($MN)
  • Table 9 Global Hormone Free Sleep Aids Market Outlook, By Other Botanicals (2024-2032) ($MN)
  • Table 10 Global Hormone Free Sleep Aids Market Outlook, By Amino Acids and Derivatives (2024-2032) ($MN)
  • Table 11 Global Hormone Free Sleep Aids Market Outlook, By L-Theanine (2024-2032) ($MN)
  • Table 12 Global Hormone Free Sleep Aids Market Outlook, By Tryptophan/5-HTP (2024-2032) ($MN)
  • Table 13 Global Hormone Free Sleep Aids Market Outlook, By GABA (Gamma-Aminobutyric Acid) (2024-2032) ($MN)
  • Table 14 Global Hormone Free Sleep Aids Market Outlook, By Glycine (2024-2032) ($MN)
  • Table 15 Global Hormone Free Sleep Aids Market Outlook, By Minerals and Vitamins (2024-2032) ($MN)
  • Table 16 Global Hormone Free Sleep Aids Market Outlook, By Magnesium (2024-2032) ($MN)
  • Table 17 Global Hormone Free Sleep Aids Market Outlook, By Vitamin D, B-Complex (2024-2032) ($MN)
  • Table 18 Global Hormone Free Sleep Aids Market Outlook, By Other Ingredients (2024-2032) ($MN)
  • Table 19 Global Hormone Free Sleep Aids Market Outlook, By Product Form (2024-2032) ($MN)
  • Table 20 Global Hormone Free Sleep Aids Market Outlook, By Capsules and Tablets (2024-2032) ($MN)
  • Table 21 Global Hormone Free Sleep Aids Market Outlook, By Gummies and Chewables (2024-2032) ($MN)
  • Table 22 Global Hormone Free Sleep Aids Market Outlook, By Liquids and Sprays (2024-2032) ($MN)
  • Table 23 Global Hormone Free Sleep Aids Market Outlook, By Powders and Stick Packs (2024-2032) ($MN)
  • Table 24 Global Hormone Free Sleep Aids Market Outlook, By Teas and Functional Beverages (2024-2032) ($MN)
  • Table 25 Global Hormone Free Sleep Aids Market Outlook, By Distribution Channel (2024-2032) ($MN)
  • Table 26 Global Hormone Free Sleep Aids Market Outlook, By Offline Distribution (2024-2032) ($MN)
  • Table 27 Global Hormone Free Sleep Aids Market Outlook, By Retail Pharmacies and Drug Stores (2024-2032) ($MN)
  • Table 28 Global Hormone Free Sleep Aids Market Outlook, By Supermarkets and Hypermarkets (2024-2032) ($MN)
  • Table 29 Global Hormone Free Sleep Aids Market Outlook, By Health & Wellness Stores (2024-2032) ($MN)
  • Table 30 Global Hormone Free Sleep Aids Market Outlook, By Online Distribution (2024-2032) ($MN)
  • Table 31 Global Hormone Free Sleep Aids Market Outlook, By E-commerce Platforms (2024-2032) ($MN)
  • Table 32 Global Hormone Free Sleep Aids Market Outlook, By Company-Owned Websites (DTC) (2024-2032) ($MN)
  • Table 33 Global Hormone Free Sleep Aids Market Outlook, By End User (2024-2032) ($MN)
  • Table 34 Global Hormone Free Sleep Aids Market Outlook, By Adults (18-60 Years) (2024-2032) ($MN)
  • Table 35 Global Hormone Free Sleep Aids Market Outlook, By Geriatric Population (60+ Years) (2024-2032) ($MN)
  • Table 36 Global Hormone Free Sleep Aids Market Outlook, By Pediatric (Children/Adolescents) (2024-2032) ($MN)

Note: Tables for North America, Europe, APAC, South America, and Middle East & Africa Regions are also represented in the same manner as above.